Lancashire and South Cumbria
Formulary
Formulary
12 Ear, nose and oropharynx
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
12-02-01 Antihistamines
| Azelastine 0.15% Nasal Spray Azelair® |
|
Formulary
|
Symptomatic treatment of allergic rhinitis in adults, adolescents and children 6 years and older. |
|
| Azelastine and fluticasone nasal spray |
|
Formulary
|
Third line agent if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient. Consider OTC purchase in line with NHSE guidance on items which should not be routinely prescribed. |
 NICE: Allergic rhinitis |
|
| Azelastine Hydrochloride Rhinolast® |
|
Formulary
|
nasal spray 140 microgram per 1 actuation After tertiary referral only
|
|
|
in East LancashireLinks
LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- NICE: Allergic rhinitis